ORYZON Reports Financial Results and Corporate Update for 4th Quarter and Year Ended December 31, 2019

NEXT STORY
Generex Congratulates their Shareholders as FINRA has Officially Posted the Approval of the Generex Corporate Action and Payment of the Generex and NuGenerex Immuno-Oncology Stock Dividends on Monday, February 24, 2020
PREV STORY
PDS Biotechnology Appoints Kamil Ali-Jackson, Esq. to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global X-Ray Detectors Industry

author_avatar
NASDAQ Market News

Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients

79% of patients felt uncomfortable raising psychological and emotional concerns during their consultations1Disease recurrence ...

author_avatar
NASDAQ Market News

The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner

author_avatar
NASDAQ Market News